At Kyowa Kirin International (KKI), commitment to life is at our core. We strive to answer the unmet medical needs of patients, their families, and the medical professionals who care for them. With more than 700 people focused on this purpose, we are a rapidly growing specialty biopharmaceutical company, engaged in the development and commercialisation of innovative medicines in the therapy areas of oncology, nephrology and central nervous system (CNS) across Europe and the Middle East.

KKI, headquartered in Marlow, England, and Galashiels, Scotland, is owned by Kyowa Kirin Co., Ltd (KKC), of Japan. Founded in 1949, KKC has a successful track record in Japan and has expanded globally. Our history of innovation is built on a strong legacy of scientific discovery and fostering collaborations that accelerate the delivery of innovative medicines to patients. Grounded in our expertise in antibody engineering, we continue to investigate new molecules with the potential to contribute to the future of healthcare and make a difference in the lives of patients.

At KKI, it is our people who have helped make a real difference to our success. Working together, our employees excel in achieving results quickly and effectively, bringing diverse and unique viewpoints to the company to achieve our vision. Our passion and energy around our core values of commitment to life, innovation, integrity and teamwork help ensure that every day, each of us is focused on not just making medicines, but also making people smile. 

With our strong legacy and exciting future, KKI is looking for great people to join our team and support our commitment to life.


Life Sciences

Kyowa Kirin International plc.

Richard Johnson

Catherine Marcellier

Alina Tudor

Jill Flint

Michael Bennett

Carlos Sesmero

Daniel Davies

Marta Bello

Mo Hussain

Sarah McDonald-Barker

Patricia Fisken

The Product Strategy and Market Access team at Kyowa Kirin International plc. plays a pivotal role in ensuring the successful launch and sustained market presence of innovative medicines. This team is responsible for developing comprehensive product strategies, conducting market analyses, and optimizing market access to meet the needs of patients and healthcare providers. They collaborate with various stakeholders to navigate the regulatory landscape, secure reimbursement approvals, and establish value propositions for new and existing products in the therapy areas of oncology, nephrology, and central nervous system (CNS) across Europe and the Middle East.

Product Strategy and Market Access

Marketing and Commercial Operations

Human Resources Team

Leadership Team

Product Strategy and Market Access

About

Team members

Other teams at Kyowa Kirin International plc.

Marketing and Commercial Operations

Human Resources Team

Leadership Team